Posted by Informa Connect Life Sciences on 21 June 2023
Building an Oligo Manufacturing Partnership with Asahi Kasei Bioprocess and Axolabs
Thomas Rupp, Managing Director at Axolabs, and Chris Rombach, Senior Vice President at Asahi Kasei Bioprocess discuss the future of oligonucleotide therapeutics and the challenges associated with large-scale manufacturing while at TIDES 2023 in San Diego, California.